The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of AngioDynamics Inc. In Connection With Executive Compensation

Levi & Korsinsky, LLP is investigating AngioDynamics (NASDAQGS: ANGO), and its Board of Directors in connection with the compensation provided to certain of its executive officers.

To get more information, click here: http://zlk.9nl.com/ango. There is no cost or obligation to you.

If you own common stock in AngioDynamics and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ango.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Levi & Korsinsky, LLPEduard Korsinsky, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com

Copyright Business Wire 2010

If you liked this article you might like

Endo international, AngioDynamics Lead Biotech Movers

Endo international, AngioDynamics Lead Biotech Movers

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

5 Stocks Everyone Hates -- but You Should Love

5 Stocks Everyone Hates -- but You Should Love

AngioDynamics (ANGO) Strong On High Relative Volume Today

AngioDynamics (ANGO) Strong On High Relative Volume Today

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love